154 related articles for article (PubMed ID: 17875234)
21. [Monoclonal gammopathies of undetermined significance called "MGUS"].
Clément F
Schweiz Med Wochenschr; 1989 Jul; 119(27-28):970-8. PubMed ID: 2508215
[TBL] [Abstract][Full Text] [Related]
22. [Acute phase proteins in monoclonal gammapathies].
Dubost JJ; Ristori JM; Soubrier M; Ruivard M; Sauvezie B
Pathol Biol (Paris); 1991 Oct; 39(8):769-73. PubMed ID: 1722302
[TBL] [Abstract][Full Text] [Related]
23. [The blood coagulation system in patients with Waldenstrom's macroglobulinemia and multiple myeloma].
Kokeva RA; Zhuravlev VS
Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):10-5. PubMed ID: 4981865
[No Abstract] [Full Text] [Related]
24. [Studies of peripheral blood lymphocytes subpopulation in multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy (author's transl)].
Matsuda S; Kimura H; Tanaka T; Akizuki T; Yoshida H; Uchida T; Kariyone S
Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):485-92. PubMed ID: 99942
[No Abstract] [Full Text] [Related]
25. [Neurologic manifestations of monoclonal gammapathies].
Uldry PA; Steck AJ; Regli F
Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963
[TBL] [Abstract][Full Text] [Related]
26. Myeloma and macroglobulinemia: what are the criteria for diagnosis?
Stone MJ
Clin Lymphoma; 2002 Jun; 3(1):23-5. PubMed ID: 12141951
[TBL] [Abstract][Full Text] [Related]
27. Patterns of pulmonary involvement in systemic amyloidosis.
Celli BR; Rubinow A; Cohen AS; Brody JS
Chest; 1978 Nov; 74(5):543-7. PubMed ID: 104830
[TBL] [Abstract][Full Text] [Related]
28. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal gammopathy: natural history studied with a retrospective approach.
Steingrimsdottir H; Haraldsdottir V; Olafsson I; Gudnason V; Ogmundsdottir HM
Haematologica; 2007 Aug; 92(8):1131-4. PubMed ID: 17650445
[TBL] [Abstract][Full Text] [Related]
30. [Clinical use of intravenous immunoglobulins in bacterial infections in multiple myeloma and Waldenström's macroglobulinemia].
Paladini G; Mazzanti G; Piccinini C; Fabiani MG; Parma A; Zulli L; Tosato F
Recenti Prog Med; 1988 Mar; 79(3):105-10. PubMed ID: 3134678
[No Abstract] [Full Text] [Related]
31. [General AL-amyloidosis: a rare complication in Waldenstrom macroglobulinemia].
Zimmermann I; Gloor HJ; Rüttimann S
Praxis (Bern 1994); 2001 Nov; 90(47):2050-5. PubMed ID: 11763619
[TBL] [Abstract][Full Text] [Related]
32. Hypercalcaemia due to calcium binding IgM paraprotein in Waldenström's macroglobulinaemia.
Side L; Fahie-Wilson MN; Mills MJ
J Clin Pathol; 1995 Oct; 48(10):961-2. PubMed ID: 8537499
[TBL] [Abstract][Full Text] [Related]
33. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance.
Blade J; Lopez-Guillermo A; Rozman C; Cervantes F; Salgado C; Aguilar JL; Vives-Corrons JL; Montserrat E
Br J Haematol; 1992 Jul; 81(3):391-4. PubMed ID: 1390212
[TBL] [Abstract][Full Text] [Related]
34. Acquired von Willebrand syndrome in multiple myeloma.
Djunic I; Elezovic I; Ilic V; Tomin D; Suvajdzic-Vukovic N; Bila J; Antic D; Vidovic A; Milosevic-Jovcic N
Hematology; 2011 Jul; 16(4):209-12. PubMed ID: 21756536
[TBL] [Abstract][Full Text] [Related]
35. Thrombosis in multiple myeloma.
Zangari M; Elice F; Fink L; Tricot G
Expert Rev Anticancer Ther; 2007 Mar; 7(3):307-15. PubMed ID: 17338651
[TBL] [Abstract][Full Text] [Related]
36. Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual.
Wang E; Kulbacki E; Stoecker M
Hum Pathol; 2012 Jul; 43(7):1135-41. PubMed ID: 22404949
[TBL] [Abstract][Full Text] [Related]
37. Identification of the paraproteins and clinical significance of more than one paraprotein and clinical significance of more than one paraprotein in serum of 56 patients.
Gore ME; Riches PG; Kohn J
J Clin Pathol; 1979 Apr; 32(4):313-7. PubMed ID: 109473
[TBL] [Abstract][Full Text] [Related]
38. [Neurologic manifestations in the course of monoclonal gammopathies. Review of the literature and description of 5 cases of multiple myeloma and 2 cases of Waldenstrom's macroglobulinemia with various involvements of the nervous system].
Azzena D; Ghigliotti G; Astengo F; Costa U; Molinelli G
Haematologica; 1967; 52(12):999-1031. PubMed ID: 4974264
[No Abstract] [Full Text] [Related]
39. The Immunotyping Distribution of Serum Monoclonal Paraprotein and Environmental Impact on Multiple Myeloma (MM) and Monoclonal Gammopathy of Uncertain Significance (MGUS) in Taiwan: A Medical Center-Based Experience.
Chang CC; Su MJ; Lee SJ; Tsai YH; Kuo LY; Lin IH; Huang HL; Yen TH; Chu FY
Asian Pac J Cancer Prev; 2016; 17(1):395-9. PubMed ID: 26838245
[TBL] [Abstract][Full Text] [Related]
40. Serum osteocalcin in the management of myeloma.
Williams AT; Shearer MJ; Oyeyi J; Aitchison RG; Newland AC; Schey SA
Eur J Cancer; 1992; 29A(1):140-2. PubMed ID: 1445731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
